V-Bio Ventures is a Ghent life-sciences investor that co-creates companies and finances differentiated therapeutic programmes. It backs drug discovery and development businesses emerging from European research from formation through mid-stage rounds.
At a glance
Investment focus
Source and review
Profile reviewed on . Investment criteria are attributed to V-Bio strategy, portfolio and geographic focus.
European mandate
- Geographic fit
- European therapeutics companies, with selected investments beyond Europe
- Round behaviour
- Creates and backs companies from early to mid-stage
